SERIES A TRACKER

Tracking Pre-Series A and Series A deals that close in India every week

Also available in a weekly newsletter every Monday morning. Sign up here.

Links out to the the websites of the startup and its investors, along with LinkedIn profiles of the founders and fundraising news.

Med-tech startup that’s reinventing how cancer diagnostics get done, by automating the core yet painstakingly manual processes in histopathology (the study of tissues). Its flagship products, RoboTome (a robotic precision cutting equipment that slices biopsy blocks) and MorphoLens (a high-throughput slide scanner using AI-driven imaging) together aim to replace labour-intensive tissue slicing and slide scanning, drastically cutting down diagnostic time while boosting consistency and scalability. Founded in Apr 2017, Bangalore and NY based. $5M Series A round led by Inflexor Ventures. Founder & CEO Rohit (IIT Kharagpur) previously worked as an engineer at Walmart Labs and was Co-founder & CEO at BigClozet (fashion discovery).

Founders
November 25, 2025
Fundraise news
Investors
Wk 48 (24-30 Nov)

Bengaluru-based biotech startup building solutions for diagnostics, gene editing and bioengineering. Its core aim is to make molecular diagnostics, genome engineering and rare-disease therapeutics accessible and affordable across human, animal health and food safety, through its platforms such as PathCrisp (for rapid diagnostics), EdiCrisp (for genome editing and strain engineering) and CurieCrisp (for preclinical & rare disease therapeutics). $3M Pre-Series A round led by Spectrum Impact (the family-office of Aarti Industries Chairman Rajendra Gogri). Founded in Oct 2020. Founders: Vijay (UCLA, MIT) was a faculty member at tge Indian Institute of Science (IISc), National Institute of Advanced Studies and also a council member at ABLE India, UNESCO's panel on Science & Technology for Development. No background information available on co-founders Sunil and Aditya.

Founders
November 25, 2025
Fundraise news
Investors
Wk 48 (24-30 Nov)

Medical devices startup that designs and manufactures surgical navigation systems, i.e. devices that use images from CT or MRI scans to project how instruments shoule be placed. The company's devices are used for complex cranial, spine and ENT procedures, with the aim of making advanced image-guided surgery accessible to hospitals of all sizes. Its main product, easyNav, integrates with existing operating room infrastructure and has been used in over 20K surgeries. $5M Pre-Series A round. Other investors in the round: India EXIM Bank, KITVEN. Founded in Jan 2015, Bangalore based. Founders: CEO Arpit Paliwal previously served in multiple roles at Stryker Corporation, one of the world's largest medical devices companies (revenue: $22B) - as a business manager, product manager and tech lead in India; no background information available on COO Shweta Paliwal.

Founders
November 12, 2025
Fundraise news
Investors
Wk 46 (10-16 Nov)

Aether MindTech is a Hyderabad-based neuro-wellness startup that’s redefining mental health through science-backed wearables. Its flagship product, Evolv28, is a device worn around the neck and delivers ultra-low magnetic fields to promote stress relief, better sleep, focus, and overall mindfulness. The device is backed by roughly 4 years of R&D and comes with multiple safety certifications like FCC, CE, and WPC. ₹4.5CR Pre-Series A round, backed by Anthill Angel Fund, MeitY Startup Hub–linked investors, and deep-tech family offices (Max Nemmers and Radhika Laxmikanth) to accelerate clinical trials, regulatory approvals, product advancement, and market expansion. Co-founder and CEO P V Shyam Sunder leads the vision and clinical strategy, while Co-founder and CTO Sreeram Vanga heads product innovation and R&D execution.

Founders
August 20, 2025
Fundraise news
Investors
Wk 34 (18-24 Aug)

Zeus Hygia is a research-led nutraceutical ingredient company, making high-quality health ingredients from plants, backed by science. These ingredients go into supplements, medicines, skincare and food products made by other brands. They focus on solving problems like joint pain, weight issues, hormonal health, ageing and energy levels, using natural extracts that are clinically tested and patented. Based in Hyderabad, they sell to companies in 15+ countries and have recently expanded to the U.S. Their tech ensures the ingredients are safe, effective, and easy for the body to absorb. $2.5 M Series A round led by NABVENTURES (the venture arm of NABARD). The CEO and Co-founder, Dr.  Arunkanth Krishnakuma is a PhD in nutraceutical sciences who drives the company’s scientific strategy and innovation agenda. The CTO, director and Co-founder- Shankaranarayanan Jeyakodi heads the technical and platform development teams responsible for science‑driven formulation technologies.

Founders
July 16, 2025
Fundraise news
Investors
Wk 29 (14-20 Jul)
Jul 16

Dial4242 is one of India’s first tech-enabled ambulance networks, built to ensure faster and more reliable emergency care across the country. Using a lightweight, tech-first infrastructure, the Mumbai-based startup connects users to ambulances in real time through its app and call centre, complete with automated dispatching, GPS tracking, predictable fares, and 24/7 coordination. The platform has already reduced average ambulance response times to under 12 minutes, with plans to bring it down further. It leverages partnerships with hospitals and digital platforms to democratise urgent medical access, including subscription-based emergency services and medical centres in underserved areas. ₹9CR Pre‑Series A round led by IAN Group, with investments from BioAngels, NSRCEL at IIM Bangalore, and several angel investors. Jeetendra Lalwani, Co‑founder & Director – drives the vision and strategy, inspired by a personal mission to prevent avoidable delays in emergencies. Nilesh Mahambre, Co‑founder – shapes product and operational excellence. Atin Verma, Co‑founder – adds leadership to technology and network scale

Founders
July 16, 2025
Fundraise news
Investors
Wk 29 (14-20 Jul)

Lamark Biotech is an Ahmedabad-based biopharma startup working to make essential biologic drugs like insulin and antibodies easier to store and transport. Their core innovation, the ProteoStrong platform, helps stabilize these drugs so they don’t need constant refrigeration, which is a major barrier in low-resource or remote areas. By removing cold-chain dependence, Lamark aims to make life-saving treatments more accessible and affordable, especially in places where medical infrastructure is limited. $ 6.5CR Pre‑Series A round led by IAN Group (via IAN Alpha Fund and BioAngels). It also included angel participation from Dr Vinayender Tulla, Dr Nita Roy, and Venkataraman KNK, all domain experts in biotech and healthcare. Two of them are not linked here. Dr Vaibhav Bhatia, Founder & CEO- biochemist turned entrepreneur who has led Lamark from campus to incubator and now to biotech innovation.

Founders
July 2, 2025
Fundraise news
Investors
Wk 27 (30 Jun - 6 Jul)
Jun 27

Jobizo is a Gurgaon-based HR-tech startup modernizing healthcare staffing by linking hospitals and clinics with vetted medical professionals—doctors, nurses, lab technicians—available for both temporary and long-term roles. Leveraging AI-powered matching and compliance tools, the platform has facilitated over 18,500 short-term assignments and 875 full-time hires in India, and manages a network of 60,000+ healthcare workers, operating across more than 41 countries . $1.4M Pre‑Series A round led by Alkemi Growth Capital, with follow-on investments from Inflection Point Ventures and Incubate Fund Asia . Naveen Trehan, Co‑founder & Chairman – leads strategic vision, and previously co-founded IFANglobal. Avishek Agarwal, Co‑founder & CEO – heads product roadmap and growth, with prior experience in healthcare recruitment at IFANglobal.

Founders
June 27, 2025
Fundraise news
Investors
Wk 26 (23-29 Jun)

Seed deals that closed each week, every Monday morning.

Thank you. You will receive our newsletter from the following Monday.
Oops! Something went wrong while submitting the form.
Receive a weekly summary of pre-seed and seed deals that close. You can unsubscribe anytime.